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Summary
Long-term hematopoietic stem cells (LT-HSCs) maintain hematopoietic output throughout an 
animal’s lifespan. However, with age the balance is disrupted and LT-HSCs produce a myeloid-
biased output, resulting in poor immune responses to infectious challenge and the development of 
myeloid leukemias. Here, we show that young and aged LT-HSCs respond differently to 
inflammatory stress, such that aged LT-HSCs produce a cell-intrinsic, myeloid-biased expression 
program. Using single-cell RNA-seq, we identify a myeloid-biased subset within the LT-HSC 
population (mLT-HSCs) that is prevalent among aged LT-HSCs. We identify CD61 as a marker of 
mLT-HSCs, and show that CD61-high LT-HSCs are uniquely primed to respond to acute 
inflammatory challenge. We predict several transcription factors to regulate mLT-HSCs gene 
program, and show that Klf5, Ikzf1 and Stat3 play an important role in age-related inflammatory 
myeloid bias. We have therefore identified and isolated a LT-HSC subset that regulates myeloid 
versus lymphoid balance under inflammatory challenge and with age.
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Hematopoietic stem cells display transcriptional and phenotypic heterogeneity that is 
quantitatively altered with age and leads to the age-dependent myeloid bias evident after 
inflammatory challenge.
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Introduction
Long-term hematopoietic stem cells (LT-HSCs) encounter continued stresses throughout life, 
yet maintain appropriate immune cell output (Akunuru and Geiger, 2016; Denkinger et al., 
2015; Dykstra et al., 2011; Geiger et al., 2013; Morita et al., 2010; Sawai et al., 2016; 
Yamamoto et al., 2018). These stresses include replicative stress (Bernitz et al., 2016; Flach 
et al., 2014; Wang et al., 2012), as well as acute and chronic infectious challenge (King and 
Goodell, 2011; Nagai et al., 2006). Physiologic aging in both humans and mice leads to 
permanent changes in LT-HSC function, such as myeloid-biased hematopoietic output, and 
poor response to infections (Akunuru and Geiger 2016). This is often accelerated in settings 
of chronic inflammation and, when dysregulated, can lead to replicative exhaustion and 
extramedullary hematopoiesis (Esplin et al., 2011; Mehta et al., 2015).
Hematopoietic stem and progenitor cells (HSPCs) express innate immune receptors (King 
and Goodell, 2011), such as toll-like receptors (TLRs), and respond to many inflammatory 
mediators, including IFN-γ (Baldridge et al., 2010), M-CSF (Mossadegh-Keller et al., 
2013), and the gram-negative bacterial component lipopolysaccharide (LPS) (Nagai et al., 
2006). In response to acute LPS exposure, LT-HSCs increase proliferation, mobilize to the 
peripheral bloodstream (King and Goodell, 2011), and initiate emergency myelopoiesis to 
increase the system’s output of innate immune cells (Haas et al., 2015). This increased 
output may also be mediated by hematopoietic progenitors, such as multipotent progenitors 
(MPPs) (Pietras et al., 2015; Young et al., 2016), in part due to direct secretion of cytokines 
that drive myeloid differentiation (Zhao et al., 2014).
Several hypotheses have been proposed to explain the age related changes in LT-HSC 
function (Kovtonyuk et al., 2016). First, cell-intrinsic changes within each aged LT-HSC 
might make it inherently myeloid-biased (Grover et al., 2016; Rossi et al., 2005). Second, 
the LT-HSC population may be comprised of subsets of myeloid- and lymphoid-biased cells, 
the composition of which changes with age such that myeloid-biased LT-HSCs are more 
prevalent within the aged LT-HSC population (Dykstra et al., 2007; Gekas and Graf, 2013; 
Yamamoto et al., 2013). The true nature of these age-related changes may in fact be a 
combination of both of these hypotheses, such that with age there is a growing subset of 
more intrinsically myeloid-biased LT-HSCs.
The transcriptional and functional state of LT-HSCs in steady state and in response to 
inflammatory mediators may help shed light on these questions, but is currently still poorly 
understood. A number of epigenomic and transcriptomic changes have been observed during 
bulk and single-cell expression analysis of young and aged LT-HSCs (Cabezas-Wallscheid et 
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al., 2014; Grover et al., 2016; Kowalczyk et al., 2015; Sanjuan-Pla et al., 2013; Sun et al., 
2014; Yu et al., 2016). However, it is unclear if and how these changes lead to altered LT-
HSC function, as seen with age-related myeloid bias (Dykstra et al., 2011; Gekas and Graf, 
2013; Yamamoto et al., 2018). In particular, a previous study using single-cell RNA-seq 
(scRNA-seq) (Kowalczyk et al., 2015) of steady-state, resting LT-HSCs has not identified a 
subpopulation structure. An understanding of how inflammatory mediators effect LT-HSCs 
response and how this response changes with age may therefore help elucidate the 
underlying mechanism of age-related myeloid bias. This may further provide insight into 
age-related pathologies, such as improper immune responses to vaccines or infectious 
challenge, and the development of myeloid leukemia.
In this work, we investigate the acute inflammatory response of mouse HSPCs in vitro and 
in vivo, and how this response may be altered with age (Figure 1A). We show that major 
HSPC subtypes respond transcriptionally to inflammatory stimuli and that age-dependent 
inflammatory myeloid bias is intrinsic to LT-HSCs, based on bone marrow transplant 
experiments. Using scRNA-seq we find that the LT-HSC compartment is comprised of at 
least two subsets that become apparent upon stimulation. One of these subsets has features 
consistent with myeloid-bias (referred to as mLT-HSCs), with distinct cell-intrinsic 
responses to inflammatory stimulation. The myeloid-biased subset expresses high levels of 
the surface marker CD61, can be prospectively isolated and lead to myeloid bias upon 
reconstitution, and increases dramatically with age. We further identify putative 
transcriptional regulators of mLT-HSCs, and demonstrate the role of these regulators in age-
related myeloid bias and differential responses to TLR ligands.
Results
Inflammation in aged and young mice leads to differential increases in myeloid output
To investigate the acute inflammatory response of hematopoietic progenitors from mice at 
different ages, we challenged 8–12 week old (‘young’) and 20–24 month old (‘aged’) mice 
with a single intraperitoneal injection of LPS (0.5mg/kg, Figure S1A-D). We observed a 
greater than twofold increase in peripheral blood myeloid frequencies in aged mice by 72 
hours post-challenge, whereas only a minimal increase was seen in young mice (Figure 
S1A,B). These changes in myeloid output returned to baseline frequencies by 9 weeks post-
challenge. The baseline frequency of T cells in aged mice was twofold lower than in young 
mice but both cohorts had increased T cell output 72 hours after LPS challenge (Figure 
S1C). In contrast, B cell output in both young and aged cohorts were decreased after LPS 
treatment, and the acute response was particularly dramatic in aged mice, which had a 
twofold loss in the frequency of B cells by 72 hours, and then recovered to baseline levels by 
6 weeks post-challenge (Figure S1D). Aged mice therefore demonstrated a strong acute 
increase in myeloid output in response to inflammatory challenge that was not observed in 
young mice.
To evaluate the cumulative effect of acute inflammatory challenges on myeloid output, we 
performed a second LPS injection to all cohorts 1 month after the initial challenge. This 
resulted in an upregulation of peripheral blood myeloid cells in aged mice whereas again, 
only a milder increase in myeloid output was seen in young mice (Figure 1B,C). 
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Interestingly, while myeloid output in young mice returned to baseline within 3 weeks, aged 
mice myeloid cell frequencies mildly decreased 3 weeks post injection, but remained higher 
than baseline for at least 9 weeks post injection (Figure 1B,C). T cell levels slightly 
increased in young mice by 72 hours and did not change in aged mice (Figure 1D). 
Conversely, B cell output decreased in both aged and young mice by 72 hours, but while 
young B cells returned to baseline levels, aged mice B cell levels remained lower than 
baseline by 9 weeks post injection (Figure 1E).
The spleens of stimulated aged mice revealed increased myeloid cell frequencies and a 
dramatic loss of T cells compared to young mice (Figure S1E). Finally, bone marrow of 
stimulated aged mice had a three-fold enrichment for LT-HSCs compared to stimulated 
young mice, with a milder enrichment in short-term HSCs (ST-HSCs) and MPPs (Figure 
S1F). This enrichment in LT-HSCs is higher than the two-fold enrichment reported between 
unstimulated aged and young mice (Beerman et al., 2010; Mehta et al., 2015). These results 
suggest that repeated acute inflammatory stimuli in aged mice enhance myeloid-biased 
output from HSPCs and that the differences in immune cell output might originate from LT-
HSCs.
Inflammation leads to a distinctive, long-term myeloid-biased output in aged LT-HSCs
To examine whether inflammation leads to a cell-intrinsic myeloid bias in LT-HSCs, we 
tested the impact of stimulation on the ability of young and aged LT-HSCs to reconstitute the 
immune system. Specifically, we first sorted LT-HSCs, ST-HSCs and MPPs from young and 
aged CD45.2 C57BL/6 mice. The sorted cells were either maintained unstimulated or 
stimulated with LPS and Pam3csk4 for 2 hours in vitro, and subsequently transplanted into 
lethally irradiated young CD45.1 C57BL/6 mice. Peripheral blood counts of CD45.2 
expressing cells were monitored for four months (Figure 1F-I and Figure S2A,B). Both 
unstimulated and stimulated, young and aged LT-HSCs demonstrated long-term 
reconstitution of the immune system in primary, as well as secondary transplanted mice 
(Figure S2A-D).
At 3 months post-reconstitution (i.e.3 months after the in vitro LPS and Pam3csk4 
challenge), inflammatory challenge of young LT-HSCs did not lead to altered peripheral 
blood myeloid and lymphoid cell frequencies compared to unstimulated controls (Figure 1F-
I). As previously reported (Beerman et al., 2010; Pang et al., 2011), unstimulated aged LT-
HSCs had higher peripheral blood myeloid output and lower lymphoid output compared to 
unstimulated young LT-HSCs (Figure 1F-I). However, stimulated aged LT-HSCs 
demonstrated a marked additional increase in the frequency of peripheral blood myeloid 
cells (Figure 1F,G) and a further decrease in the frequency of peripheral blood B cells 
(Figure 1H). Thus, aged LT-HSCs demonstrated myeloid-biased ‘memory’ of the initial in 
vitro LPS and Pam3csk4 challenge that persisted for several months post-reconstitution, a 
phenomenon not seen with stimulated young LT-HSCs. Interestingly, no significant 
difference in LT-HSC frequency was observed between cohorts, including in the previously 
identified myeloid-biased CD41+ LT-HSC subpopulation (Gekas and Graf, 2013) (Figure 
S2E-H). These results suggest that direct TLR stimulation of aged LT-HSCs leads to a long-
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term increase in myeloid bias. It is not clear, however, whether this increase is cell intrinsic 
or due to changes in composition of LT-HSCs population.
HSPCs demonstrate a canonical transcriptional response to TLR ligands
We hypothesized that the differential effects of young and aged stimulated LT-HSCs may be 
due to a variable transcriptional response to inflammatory signals. To test this hypothesis, we 
measured the transcriptional profiles of populations of HSPCs from young and aged mice 
during a 12-hour time-course of LPS and Pam3csk4 stimulation in vitro (Figure 2A). LT-
HSCs, ST-HSCs and MPPs from both young and aged mice all demonstrated a robust and 
similar transcriptional response to inflammatory stimuli (Figure 2B and Table S1), which 
largely resembled that seen in mature cell types with different physiological functions, such 
as bone marrow derived dendritic cells (BMDCs) after LPS stimulation (Figure 2B-D) 
(Jovanovic et al., 2015). This includes the same temporal ordering of induction in 
inflammatory gene clusters as in mature cell types (Amit et al., 2009; Ramirez-Carrozzi et 
al., 2009), up-regulation of NF-κB-related genes (Figure 2C) (Bhatt et al., 2012; Hao and 
Baltimore, 2009), and induction of the expression of several effector cytokines (Figure 2D), 
albeit at slightly lower levels (Figure S3A-C). Among the differentially expressed genes 
between all cell types, HSPCs from both young and aged mice presented similar patterns 
compared to BMDCs (Figure 2B; for a complete list of differentially expressed genes and 
their Gene Ontology (GO) enrichments see Table S2). Thus, the response of young and aged 
HSPCs to inflammatory activation resembles the canonical response of mature cells to 
similar stimulation, both in the identity of the regulated genes and in the timescale of the 
response. This suggests that the differences in the reconstitution outcome were not simply 
related to differences in the transcriptional response when measured at the population level.
Single-cell RNA-seq reveals two subsets of LT-HSCs with distinct responses to 
inflammatory stimulus
Next, we considered the possibility that there are different subsets of LT-HSCs either in 
steady state or post-stimulation (“cell intrinsic changes”), and that their relative proportions 
may change with age (“compositional changes”). Early hematopoietic progenitors are 
comprised of heterogeneous functional subpopulations (Benz et al., 2012; Gekas and Graf, 
2013; Morita et al., 2010; Sanjuan-Pla et al., 2013), which often reveal themselves in 
response to inflammatory stimuli (Haas et al., 2015; Zhao et al., 2014). While a previous 
scRNA-seq study we performed of LT-HSCs has mostly revealed age-related differences in 
the cell cycle (Kowalczyk et al., 2015), we hypothesized that stimulation could unveil 
additional cell intrinsic distinctions that were not observed in resting cells.
To determine the composition of HSPCs in each age group and condition, we performed 
full-length scRNA-seq (Picelli et al., 2013) of young and aged LT-HSCs, ST-HSCs and 
MPPs, with and without 2 hours of in vitro LPS and Pam3csk4 stimulation of sorted cells. 
As we aimed to distinguish cell intrinsic, possibly subtle, stimulus-specific states within a 
very well-defined cell population, we opted for the deeper-coverage full length scRNA-Seq 
approach over massively parallel approaches (Tanay and Regev, 2017; Wagner et al., 2016). 
We profiled 2,046 individual cells from nine mice (5 young, 4 aged), with 124–186 cells for 
each given cell type and condition. In order to eliminate sources of variability resulting from 
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known confounding factors, we removed 611 cells as low-quality and 58 as possible 
contaminants (STAR-Methods). In addition, 578 of the cells were actively cycling (STAR-
Methods). Overall, we retained 949 cells for subsequent analysis, comprised of 187 MPPs, 
404 ST-HSCs, and 358 LT-HSCs.
We identified three major groups of cells using unsupervised clustering (STAR-Methods), 
denoted clusters 1, 2 and 3 (Figure 3A). Cluster 1 (311 cells) contained most (302 of 354) of 
the unstimulated HSPCs of all types, forming a continuum from MPPs to LT-HSCs (Figure 
3B), with aged and young LT-HSCs clustering together (Figure 3D), and hardly any 
stimulated cells. Clusters 2 (103 cells) and 3 (421 cells) almost exclusively contained 
stimulated HSPCs (Figure 3C), and had opposing patterns with respect to aged and young 
LT-HSCs (Figure 3E): cluster 3 contained 77% of the aged stimulated LT-HSCs and only 
13% of the young stimulated LT-HSCs, whereas cluster 2 had 72% of the young stimulated 
LT-HSCs, and only 10% of the aged stimulated LT-HSCs (Figure 3E). This suggests that 
there are distinct subsets of LT-HSCs in the bone marrow that can be discerned by their 
different cell intrinsic responses to stimulation, and that the relative frequencies of these 
subsets appear to change with age. Of note, the distinction between these LT-HSC subsets 
could only be discerned with stimulation, and no significant difference was found within 
unstimulated or stimulated ST-HSCs or MPPs (Figure S3D,E). Given these findings, we 
focused further analysis on LT-HSCs.
Myeloid-biased LT-HSCs can be identified by a distinct gene signature under inflammatory 
conditions
To identify the differences between stimulated LT-HSCs in cluster 3 and cluster 2, we 
examined genes that were differentially expressed between the two clusters. Cluster 3-
specific genes were enriched for genes related to myeloid function and inhibiting lymphoid 
differentiation, including pathways related to NF-κB localization, negative regulation of 
lymphocyte development, macrophage proliferation, cell migration and localization, and 
platelet derived growth factor signaling (Figure S3F). Cluster 2-specific genes were enriched 
for genes involved in lymphocyte development, cell proliferation, and the acute 
inflammatory response (Figure S3G). Cells in any given cluster, regardless of age, were 
similar to each other and distinctly different from cells in the other cluster. These data are 
consistent with a model where aged and young LT-HSCs have different proportions of cells 
that display unique lineage-biased pathway preferences in response to inflammatory signals.
To test whether the LT-HSC subsets also exist in unstimulated cells in steady-state 
conditions, we identified 47 genes that were significantly differentially expressed both when 
comparing cluster 3 vs.cluster 2 (single cell differential expression, ‘SCDE’ (Kharchenko et 
al., 2014), FDR < 0.01) and when comparing unstimulated aged vs. young LT-HSCs within 
cluster 1 (Figure S3H; STAR-Methods, SCDE FDR < 0.1). We then tested whether these 47 
genes coherently co-vary across the 149 unstimulated LT-HSCs, and thus might reflect a 
variable cell state within these cells. Indeed, we identified three distinct co-varying gene 
clusters (Figure 3F), two of which contained genes involved in myeloid and platelet 
differentiation, including Selp,Vwf, Gpr64, Plscr2, and Wdfy1. Notably, recent studies have 
reported myeloid-biased CD41, Vwf or CD150-high expressing LT-HSC subpopulations 
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(Dykstra et al., 2011; Gekas and Graf, 2013; Sanjuan-Pla et al., 2013); in our analysis, aged 
LT-HSCs have increased yet variable expression of CD150 and Vwf, and no significant 
difference in CD41 expression (Figure S3I-K).
Next, we generated a refined gene signature. We first scored unstimulated LT-HSCs with the 
initial set of 47 genes (Figure S3H), identifying two putative cell subsets (STAR Methods). 
Next, we used these subsets to initialize k-means clustering (k=2) within the unstimulated 
LT-HSCs. We used the identities of the cells based on this clustering to designate them as 
myeloid-biased LT-HSCs (mLT-HSCs), and non-myeloid biased LT-HSCs (nmLT-HSCs).We 
tested these two final clusters for differentially expressed genes, finding 365 upregulated 
genes and 34 downregulated genes in the mLT-HSC cluster, which we use to define our 
“mLT-HSC signature” (SCDE FDR < 0.1 and the same direction of change as for stimulated 
mLT-HSCs) (Table S3).
In the final k-means clusters, 92% of cells in the myeloid biased cluster were aged cells and 
only 8% were young cells (Figure 3G, to the right of the dashed line), while only 20% of 
cells in the non-myeloid biased cluster were aged cells and 80% were young cells (Figure 
3G, to the left of the dashed line). This is consistent with our findings that the frequency of 
stimulated mLT-HSCs increases with age (Figure 3E). Applying the same signature to our 
stimulated LT-HSCs or to an independent dataset of unstimulated aged and young LT-HSCs 
from two mouse strains (Kowalczyk et al., 2015) showed consistent results: while the LT-
HSC population is inherently heterogeneous, more aged LT-HSCs score highly for the mLT-
HSC signature (Figure S3L,M). Thus, the mLT-HSC signature allowed us to identify the 
subtle portion of myeloid-biased like cells among the young unstimulated LT-HSCs, and to 
show that the proportion of high-scoring mLT-HSC cells rises with age.
Klf5, Ikzf1 and Stat3 regulate age-related inflammatory myeloid bias of LT-HSCs
To identify transcription factors (TFs) that may regulate differentially expressed genes 
between the mLT-HSC and nmLT-HSC subsets, we looked for enriched TF motifs in the 
enhancer sequences associated with these genes (Lara-Astiaso et al., 2014) (Figure 3H). In 
particular, we focused on TFs that themselves were differentially expressed between mLT-
HSCs and nmLT-HSCs, since altered transcriptional regulation of a TF may affect its target 
genes. Among the nine significant TFs whose motifs were enriched in enhancers of 
differentially expressed genes were HoxA9, Klf4, Klf5, Ikzf1, and Stat3, which we chose to 
further test given their known putative roles in HSPC biology (Figure 3H; blue dots).
To test the role of these TFs in age-related myeloid bias, we transplanted young or aged 
HSPCs with shRNA knockdowns of each TF into young irradiated C57BL/6 recipient mice 
(Figure S4A). Of the tested TFs in steady state, Klf5, Ikzf1, and Stat3 had significant, age-
dependent effects, whereas HoxA9 and Klf4 did not (Figure S4B-E). Consistent with the 
upregulated expression of Klf5 in mLT-HSCs, we found that knockdown of Klf5 in aged LT-
HSCs resulted in increased lymphoid output (Figure S4C) and decreased myeloid output to 
levels seen with control young LT-HSCs (Figure S4D,E). There was no immediately 
apparent effect of Klf5 knockdown in young LT-HSCs. Knockdown of Ikzf1 in young LT-
HSCs resulted in decreased lymphoid output (Figure S4C). Interestingly, loss of Ikzf1 in 
aged LT-HSCs had no significant effect on lymphoid output, but like knockdown of Klf5, it 
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resulted in decreased myeloid output to levels seen with control young LT-HSCs (Figure 
S4D,E).
We next tested whether these TFs regulate myeloid output of LT-HSCs under conditions of 
inflammatory stress. To do this, we challenged the aforementioned shRNA knockdown mice 
with LPS (as in Figure 1B-E). As expected, after the LPS challenge, mice transplanted with 
control aged LT-HSCs showed a sustained upregulation of myeloid output over the 3 weeks 
(Figure 4A-C, solid red lines), whereas mice transplanted with control young HSPCs had 
only a transient increase in myeloid output followed by rapid recovery to baseline (Figure 
4A-C, solid black lines). The response to LPS of mice transplanted with aged HSPCs 
expressing Klf5, Ikzf1 or Stat3 shRNAs phenocopied that of mice transplanted with control 
young HSPCs (Figure 4A-C and Figure S4F-H, dashed red lines). Thus, Klf5, Ikzf1and 
Stat3 may play a critical role in regulating inflammatory myeloid bias in aged LT-HSCs. No 
dysregulation in immune output was seen in mice transplanted with HSPCs expressing 
HoxA9, Klf4 or Zbtb4 shRNAs (data not shown).
To identify the cell types responsible for the changes observed after Ikzf1, Stat3 or Klf5 
knockdown in aged HSPCs, we analyzed the bone marrow compartment of all mice 3 
months post-transplantation. Mice transplanted with aged control cells had higher LT-HSC 
and CMP frequencies, and lower CLP frequencies, but no changes in other early progenitor 
populations when compared to mice reconstituted with young control cells (Figure 4D-F and 
Figure S4I-K). Knockdown of either Klf5, Ikzf1 or Stat3 in transplanted aged HSPCs 
resulted in a decreased frequency of LT-HSCs compared to control aged HSPCs (Figure 4D). 
We observed no significant effect on the frequency of LT-HSC in the bone marrow in mice 
transplanted with young HSPCs expressing any of these knockdown constructs (Figure 4D, 
grey bars) or in aged HSPC transplanted mice expressing HoxA9 or Klf4 shRNAs (data not 
shown). These data therefore suggest that Klf5, Ikzf1 and Stat3 may regulate inflammatory 
myeloid bias in aged LT-HSCs and may do so by altering the function and frequency of LT-
HSCs in the bone marrow compartment.
To investigate if the expression of Ikzf1, Stat3 and Klf5 is sufficient to skew the LT-HSC 
output, we over-expressed these genes in young and aged HSPCs, and transplanted these 
cells into young irradiated C57BL/6 mice (STAR Methods). Ikzf1 and Klf5 overexpression 
(OE) led to an increase in myeloid output and decrease in lymphoid output at 3 months post-
reconstitution with both young and aged HSPC donor cells (Figure 4G-I and Figure S5A-C). 
A significant increase in myeloid output was observed after a single LPS injection in Ikzf1 
and Klf5 OE mice compared to age appropriate controls. Conversely, Stat3 OE in both 
young and aged donor HSPCs yielded comparable myeloid output, which resembled that of 
aged control mice following LPS injection (Figure 4G-I and Figure S5A-C, dashed lines). 
Analysis of the bone marrow compartment of Klf5 OE mice revealed a marked increase in 
the frequency of LT-HSCs, but no differences in frequency of ST-HSCs or MPPs. Klf5 OE 
did affect downstream progenitors, yielding a higher frequency of bone marrow CMPs and 
GMPs, and a decrease in frequency of CLPs in both young and aged donors compared to 
age-matched controls (Figure 4J-L and Figure S5D-H). Similarly, Ikzf1 OE in both young 
and aged mice resulted in an increase in bone marrow LT-HSC frequency and decrease CLP 
and LMPP frequencies. Stat3 OE did not significantly alter LT-HSC frequencies in young or 
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aged mice (Figure 4J-L and Figure S5D-H). This data therefore suggests that Klf5, Ikzf1and 
Stat3 may be necessary and sufficient to promote inflammatory myeloid bias.
CD61 is a marker for mLT-HSCs
To identify putative surface markers that may characterize mLT-HSCs, we searched the set 
of genes that were differentially expressed between mLT-HSCs and nmLT-HSCs for those 
encoding surface proteins that also have a commercially available antibody (Figure S6A and 
Table S4). Among the surface proteins whose gene expression was elevated in mLT-HSCs 
compared to nmLT-HSCs were CD61 (Itgb3), CD62p, CD166, CD38 and CD34 (Figure 
S6A). We tested the surface expression of five of these proteins in aged and young LT-HSCs 
using flow cytometry (Figure 5A and S6B), and identified CD61 as the most differentially 
expressed surface protein between the two populations (Figure 5A). The relative proportion 
of high CD61 expressing LT-HSCs (CD61-high LT-HSCs) and low CD61 expressing LT-
HSCs (CD61-low LT-HSCs) was consistent with the proportions of mLT-HSCs and nmLT-
HSCs, respectively, as identified in aged and young mice (Figure S6C, D). CD61 encodes 
for β3 integrin. In hematopoietic cells, CD61 has been shown to heterodimerize with αV/
CD51, α5/CD49e, and αIIB/CD41 to form αVβ3, α5β3, or the platelet specific 
αIIBβ3integrins, respectively (Nemeth et al., 2007; Shattil et al., 1998). Using flow 
cytometry, we found that on LT-HSCs CD51 expression levels correlates most to that of 
CD61, while CD49e and CD41 expression was only partially correlated with CD61 (Figure 
S6E-G, Figure S2F,H).
We next tested if CD61-high LT-HSCs are functionally myeloid biased. We sorted CD45.2 
CD61-high and CD61-low LT-HSCs (Figure S6C,D) from both young and aged mice, and 
transplanted them into young lethally irradiated CD45.1 C57BL/6 mice. At three months 
post-reconstitution, the peripheral blood from mice transplanted with either young or aged 
CD61-high LT-HSCs had decreased T cell and B cell output, and increased myeloid and 
granulocyte output (Figure S7A-D), compared to mice transplanted with young CD61-low 
cells. To test if CD61-high LT-HSCs are more prone to inflammatory myeloid bias, we 
challenged these transplanted mice with LPS. Mice transplanted with both young and aged 
CD61-high LT-HSCs had a more pronounced and sustained increase in peripheral blood 
myeloid and decrease in lymphoid output 3 weeks post-challenge when compared to mice 
transplanted with total LT-HSCs and CD61-low LT-HSCs of comparable age (Figure 5B-E 
and Figure S7E-H).
To investigate the cellular basis of myeloid bias with transplant of CD61-high LT-HSCs, we 
harvested bone marrow from all transplanted mice and analyzed for early hematopoietic 
progenitors. The bone marrow of mice that had received CD61-high LT-HSCs, whether 
young or aged, had increased frequencies of LT-HSCs (Figure 5F) of which the majority 
were CD61-high LT-HSCs compared to mice transplanted with CD61-low LT-HSCs (Figure 
5G; 56% and 74% of total LT-HSCs in mice transplanted with young and aged CD61-high 
LT-HSCs, respectively). The frequency of CD61-high LT-HSCs in mice transplanted with 
either young or aged CD61-low LT-HSCs were similar to that of mice transplanted with total 
LT-HSCs of young mice, and over three-fold lower than that of mice transplanted with 
CD61-high LT-HSCs or total aged LT-HSC mice (Figure 5G). This suggests there CD61-low 
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LT-HSCs may have the potential to convert to a CD61-high LT-HSC phenotype. Consistent 
with their myeloid-biased phenotype, mice transplanted with CD61-high LT-HSCs had 
decreased bone marrow CLPs (Figure 5H), and increased GMPs, CMPs and MEPs (Figure 
5I-K) compared to mice transplanted with CD61-low LT-HSCs, regardless of age.
Discussion
In this work, we demonstrate that LT-HSCs have a heterogeneous response to inflammatory 
stimuli that is altered with age. We show that even the most multipotent of HSPCs directly 
respond in vitro to TLR ligands with a potent transcriptional response. Using scRNA-seq, 
we demonstrate that both the young and aged LT-HSC compartments are comprised of at 
least two distinct subsets of cells with a defined molecular signature. We identify CD61 as a 
marker of inflammation-responsive myeloid-biased LT-HSCs (mLT-HSCs). We posit that an 
increased proportion of mLT-HSCs in the bone marrow is a key driver of myelopoiesis and 
further identify several transcription factors that regulate steady state and inflammatory 
myeloid bias in aged LT-HSCs. Together, our data suggests a revised model (Figure 6) of 
how inflammation impacts LT-HSC function and composition with age.
We show that various types of HPSCs respond transcriptionally to TLR ligands in vitro in a 
similar way to that seen in BMDCs after LPS stimulation (Ramirez-Carrozzi et al., 2009). 
Given the different functional roles of HSPCs and mature immune cells, this similarity in 
transcriptional response is surprising. It has been suggested that, as in mature cell types, 
inducing the expression of NF-κB with LPS and Pam3csk4 in HSPCs may affect cytokine 
secretion and proliferation (Zhao et al., 2011, 2014). We observed that the dynamics of 
expression of NF-κB-driven genes was largely similar between HSPCs and BMDCs. Thus, 
the majority of NF-κB-responsive genes appear to be regulated similarly in both HSPCs and 
mature cells.
While it has been demonstrated that TLR stimulation of LT-HSCs induces their proliferation 
(Zhao et al., 2013), our results suggest that it does not alter their long-term reconstitution 
potential. Importantly, aged LT-HSCs maintained a memory of the in vitro inflammatory 
challenge and had increased myeloid output 3 months after transplant compared to 
unstimulated aged LT-HSCs. These data therefore confirm that LT-HSCs directly sense TLR 
ligands (Nagai et al., 2006), and in response to this, the aged LT-HSC population has an 
amplified cell-intrinsic myeloid bias. In the context of physiologic aging, it might be that the 
accumulation of inflammatory challenges over the lifetime of an animal results in selection 
and expansion of mLT-HSCs, partially due to direct sensing of these inflammatory signals 
by these cells. mLT-HSCs enrichment, in turn leads to myeloid bias, further amplifying 
chronic inflammation, forming a positive feedback loop generating mLT-HSCs expansion. 
This hypothesis is supported by the fact that chronic inflammatory stimulation of young 
mice, either by repeated LPS challenge or another form of NF-κB activation, leads to 
myeloid-biased output (Esplin et al., 2011; Zhao et al., 2013). Additionally, human chronic 
inflammatory diseases such as rheumatoid arthritis in relatively young individuals present 
with functional changes in HSPCs and a myeloid bias, mirroring aged individuals (Wunder 
and Henon 2012; Colmegna et al. 2008). Given that the LT-HSC population is 
heterogeneous, it is yet to be determined whether inflammation plays a role in either 
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expanding the number of cells in the mLT-HSC state or in changing the state of nmLT-HSCs 
to an mLT-HSC-like state over time.
Using scRNA-seq, we identified subsets within the LT-HSCs population, with distinct 
transcriptional responses to inflammatory signals. Previous efforts have identified 
phenotypic markers for megakaryocyte and myeloid biased LT-HSC subpopulations 
(Dykstra et al., 2011; Gekas and Graf, 2013). The gene signature in this study provides 
functional insight into the basis of myeloid bias in the context of aging and inflammation. 
Using this gene signature from stimulated LT-HSCs, we uncovered a subset of mLT-HSC-
like cells enriched in the unstimulated aged LT-HSC compartment that have the potential to 
respond uniquely to acute inflammatory signals. This is consistent with recent results 
suggesting that there is an epigenetically primed subset of LT-HSCs that is uniquely poised 
to respond to LPS (Yu et al., 2016). We show herein that such a subset may also be identified 
using mRNA expression data.
We identified CD61 as a functional surface marker for mLT-HSCs. CD61-high LT-HSCs 
from both young and aged mice led to myeloid bias in transplantation experiments, 
confirming it as a phenotypic marker for mLT-HSCs. CD61 is the b3 integrin subunit, which 
dimerizse with ItgaV (CD51) to form the vitronectin receptor Itgb3aV predominantly 
expressed on macrophages, osteoclasts, dendritic cells and platelets. CD61 expression has 
been shown to contribute to LT-HSC repopulating efficiency (Umemoto et al., 2008), 
quiescence (Umemoto et al., 2006), and proliferation (Khurana et al., 2016). Consistent with 
this, we see that reconstitution efficiency in CD61-low LT-HSCs from both young and aged 
mice is hampered compared to CD61-high and total LT-HSCs (Figure S7I). Interestingly, our 
transplantation experiments with purified CD61-low and CD61-high LT-HSCs resulted in a 
distribution of CD61 expression in LT-HSCs resembling young and aged total LT-HSC 
transplants, respectively. This suggests that there may be plasticity between mLT-HSC and 
nmLT-HSC subpopulations, and supports the hypothesis that the composition of intrinsically 
myeloid biased LT-HSCs changes with age. While we show CD61 can be used as a 
phenotypic marker, whether it has a functional role in the formation of mLT-HSCs is yet to 
be determined.
We additionally identified several transcriptional regulators of inflammatory myelopoiesis in 
aged stimulated mLT-HSCs. Among these was Klf5, which is required for embryonic stem 
cell self-renewal (Jiang et al., 2008). The enrichment of Klf5 in mLT-HSCs may therefore 
play a role in the increased symmetric self-renewal divisions seen in aged LT-HSCs (Geiger 
et al., 2013; Sudo et al., 2000). Indeed, knockdown of Klf5in aged LT-HSCs, but not in 
young LT-HSCs, results in decreased myeloid output and decreased LT-HSC bone marrow 
frequency, while overexpression leads to the opposite effect. Consistent with these results, it 
has recently been shown that deficiency of Klf5 in LT-HSCs leads to decreased bone marrow 
homing of these cells in transplant experiments and reduced output of myeloid cells, 
especially neutrophils (Shahrin et al., 2016; Taniguchi Ishikawa et al., 2013).
The role of Ikzf1 in LT-HSC function is less well understood. Previous studies have 
suggested that Ikzf1 does not play a role in myeloid versus lymphoid lineage commitment of 
young LT-HSCs (Ng et al., 2009). Our results suggest that in the context of inflammation, 
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Ikzf1 may indeed have a positive role in myeloid fate decisions. We found that any 
perturbation of Ikzf1 expression levels affects the differentiation potential of LT-HSCs. 
Consistent with this, Ikzf1 has been shown to bind enhancer elements of both myeloid and 
lymphoid genes in human HSPCs (Novershtern et al., 2011). Knockdown of Stat3 in aged 
LT-HSCs also severely hampered myeloid output after inflammatory challenge. This is 
consistent with the role of Stat3 as a major inflammatory TF. In particular, some studies 
suggest that Stat3 is induced in response to TLR4 signaling in certain cell types 
(Kortylewski et al., 2009). Interestingly, complete knockout of Stat3in LT-HSCs has been 
shown to result in a premature aging phenotype (Mantel et al., 2012); our results suggest that 
partial loss of Stat3 is not enough to recapitulate this phenotype.
In summary, our analysis has uncovered mLT-HSCs, identified CD61, a previously 
unreported marker for inflammation-responsive myeloid-biased LT-HSCs, and revealed three 
TFs, Klf5, Ikzf1, and Stat3 as important regulators of inflammatory myeloid bias. Since 
altering the expression of these TFs can alter the balance of myeloid and lymphoid cells 
during emergency myelopoiesis, manipulating them or other aspects of the unstimulated or 
stimulated mLT-HSC programs may provide new therapeutic avenues for re-establishing 
appropriate lymphoid versus myeloid balance to improve immune function and prevent 
myeloid leukemias with age.
STAR Methods
Contact for reagent and resource sharing
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact - Mati Mann, mati@caltech.edu
Experimental model and subject details
Mice—The California Institute of Technology Institutional Animal Care and Use 
Committee approved all experiments. Young and aged C57BL/6 WT males and females 
mice were obtained from Charles Rivers Laboratories and housed in the Caltech Office of 
Laboratory Animal Resources (OLAR) facility. For all experiments, young mice were 
between 8–12 weeks of age and aged mice were between 20–24 months of age.
Method Details
Flow cytometry—Tissues were first harvested and cells were homogenized. Samples were 
depleted of RBCs using RBC lysis buffer (BioLegend). Cells were subsequently stained with 
fluorescently labeled antibody. Respective cell types were analyzed according to relevant 
surface markers by using the following antibodies: CD45.1 and CD45.2, lineage-specific 
markers (CD11b, Gr-1, CD19, B220, CD3e, Nk1.1 and Ter119), or progenitor-specific 
markers (CD150, CD48, Flt3, CD34, FcRgamma and IL7R). All antibodies were purchased 
from BioLegend. HSPCs were sorted by first lineage-depleting whole bone marrow from 
young and aged mice. Samples were incubated with biotin-conjugated lineage antibodies 
(CD19, B220, CD4, CD8, CD11b, Gr-1, Ter119, Nk1.1, IL7Ra each at 1:200 dilution), and 
passaged through Miltenyi MACS negative selection columns. Cells were subsequently 
analyzed with a MACSQuant10 Flow Cytometry machine (Miltenyi), or sorted using BD 
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Aria sorter. HSPCs were sorted using SLAM markers with the following gating strategies: 
for MPPs: Lineage-cKit+Sca1+CD150-CD48+, for ST-HSCs: Lineage-cKit+Sca1+CD150-
CD48- and for LT-HSCs: Lineage-cKit+Sca1+CD150+CD48-, with or without CD61. 
Gating strategies for other cell types used in our analysis are described in Figure S8. 
(Complete list of antibodies catalog numbers and lots can be found in Key Resources table)
Cell culture—Cells were cultured in a sterile incubator that was maintained at 370C and 
5% CO2. Primary cells were cultured in HSPC media, comprised of complete RPMI 
supplemented with 10% FBS, 100 U/mL penicillin, 100 U/mL streptomycin, 50uM β-
mercaptoethanol and mouse SCF (50 ng/mL), IL-3 (20 ng/mL), and IL-6 (50 ng/mL) when 
cultured for reconstitution experiments. 293T cells were cultured in DMEM supplemented 
with 10% fetal bovine serum, 100 U/mL penicillin and 100 U/mL streptomycin. For in vitro 
stimulation, sorted HSPCs were incubated in HSPC media with 100ng/ml LPS (SIGMA 
CAT: L2880–100MG), and 1ug/ml Pam3csk4 (Invivogen CAT: 41–11-60–10) for the 
indicated time points.
Bone marrow transplant experiments—Bone marrow reconstitution experiments were 
performed using aged and young unmanipulated cells or with the vectors noted below. Aged 
and young WT CD45.2 C57BL/6 mice were treated with 5-fluorouracil (10ug; Sigma) for 5 
days to enrich for hematopoietic stem and progenitor cells (HSPCs) in the bone marrow. 
After 5 days, bone marrow cells were harvested, red blood cells (RBCs) were lysed with 
RBC lysis buffer (BioLegend), and cells were plated in HSPC media (see above). Cells were 
then cultured for 24 hours and spin-infected for 2 hours at 300C and 2500RPM with PCL-
ecotropic pseudotyped gamma-retrovirus expressing the shRNA or cDNA of interest (see 
Key Resources table). Virus supernatant was then removed and replaced with HSPC media. 
A second round of spin infection was performed 24 hours later. 24hrs after the last infection, 
recipient mice were lethally irradiated (1000 rads) and 250,000 virus-infected HSPCs were 
retro-orbitally delivered to reconstitute the immune system.
Recipient mice were monitored for health and peripheral blood was analyzed for mature 
blood cell types every 4 weeks or at 4 hours after each LPS injection up till secondary 
transplant, or till the experimental endpoint 16 weeks post-reconstitution. At each endpoint, 
immune organs were harvested for further analysis. The number of mice for each 
experimental cohort is described in the figure legends.
For LT-HSC, ST-HSC or MPPs, from either young or aged CD45.2 mice, donor bone 
marrow was extracted and lineage depleted cells were sorted for each cell population (see 
sorting procedure above). Cells were then processed for transplant or stimulated with LPS 
and Pam3csk4 as described above for 2 hours prior to transplantation. A total of 1000 sorted 
cells were injected together with 100,000 supporting CD45.1 bone marrow cells from young 
donors into irradiated young CD45.1 recipient mice. For secondary transplant experiments, 
250,000–500,000 cells from whole bone marrow of primary transplant mice were 
transplanted into irradiated young CD45.1 recipient mice. For CD61 reconstitution 
experiments, 100 CD61 high or CD61 low LT-HSCs from young or aged CD45.2 mice were 
injected into irradiated young CD45.1 mice together with 200,000 supporting total bone 
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marrow cells from young CD45.1 mice. Each experiment was repeated at least twice, and in 
many cases three times.
In vivo LPS challenge—Mice were injected intraperitoneally with a sublethal dose of 
LPS (0.5ug/gram, SIGMA CAT: L2880–100MG), and were bled before injections, and after 
24hrs, 7days, 14days and 7 weeks. Blood samples were analyzed for CD11b, CD3e, CD19, 
and Gr1 expressing cells to asses mature immune cell populations. In some cases, a 
secondary injection of 0.5ug/gram LPS was conducted followed by immune cell repertoire 
in peripheral blood as with the first injection. For chronic LPS injections, mice were injected 
with 0.1ug/gram twice weekly for 12weeks. Mice were then harvested, blood samples were 
analyzed for CD11b, CD3e, CD19, and Gr1 expressing cells to asses mature immune cell 
populations, and bone marrow cells were analyzed for LT-HSC, ST-HSC, MPP as well as 
CD61 on LT-HSCs.
Bulk RNA-seq—For bulk RNA-seq, LT-HSCs, ST-HSCs and MPPs from aged and young 
mice were sorted as described above. Cells were then stimulated in vitro for 0.5, 1hr, 2hr, 
4hr, 8hr, or 12hr with 100ng/ml LPS (SIGMA CAT: L2880–100MG), and 1ug/ml 
Pam3CSK4 (Invivogen CAT: 41–11-60–10). mRNA extraction was performed using the 
PrepEase RNA Spin Kit (usb®). RNA quality was assessed using RNA 6000 Pico Kit 
(Agilent). Full-length RNA-seq libraries were prepared as previously described (Kowalczyk 
et al., 2015) and paired-end sequenced (38bp x 2) on an Illumina HiSeq2500.
Single-cell RNA-seq—For full-length single-cell RNA-Seq, LT-HSCs, ST-HSCs and 
MPPs from aged and young mice were sorted as described above and stimulated in vitro for 
2 hours in large volumes (2000–3000 cells in 10mL of media) to minimize secondary 
stimulation with secreted cytokines. Single cells were subsequently sorted into 96 well 
plates containing 5ul TCL Buffer (QIAGEN) with 1% 2-mercaptoethanol, centrifuged and 
frozen at −80°C. SMART-Seq2 protocol was carried out as previously described (Picelli et 
al., 2013) with minor modifications (MSK and AR, in preparation). cDNA was amplified 
with 20 cycles and tagmented with a quarter of the standard Illumina NexteraXT reaction 
volume. Single-cell libraries were pooled and paired-end sequenced (38bp x 2) on an 
Illumina Hiseq2500 or Nextseq500.
DNA constructs—For in vivo Ikzf1, Klf4, Klf5, Hoxa9, Zbtb4, Stat3 shRNA experiments, 
the mature shRNA sequence was synthesized in the microRNA-155 loop-and-arms format 
(O’Connell et al., 2010) and cloned into the MSCV-eGFP (MG). All shRNA sequences are 
provided in Reagents and Resources. For overexpression of Ikzf1, Klf5, and Stat3, the 
cDNA of each transcription factor was cloned into a PIG vector (Mayr and Bartel, 2009) 
(Addgene plasmid # 21654). All cDNA sequences cloned are provided in Table S5. Virus 
production is described below.
Virus production—To generate retrovirus for HSPC infection, 106 HEK293T cells were 
first plated in a 15cm plate. 24 hours later, cells were transfected with both the pCL-Eco 
vector and either the MG or PIG vector with the relevant shRNA or cDNA described above 
for gene delivery. For transfection, we used BioT (Bioland Scientific) as per the 
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manufacturer’s protocol. 36 hours after transfection, virus was collected, filtered through a 
45uM syringe filter, and used for infection of HSPCs.
Quantification and statistical analysis
Bulk RNA-seq analysis—RNA-seq reads for both single cell and bulk were aligned to 
the mm9 UCSC transcriptome and quantified using RSEM (Bowtie versions 1.27 and 
0.12.7, respectively) (Li and Dewey, 2011). Gene-level counts were TMM-normalized and 
edgeR (Robinson et al., 2010) was used to call differentially expressed genes, comparing 
each time point to time 0, for all cell types and mouse ages. We also considered baseline 
differences between cell types and mouse ages. P-values were adjusted for multiple 
hypothesis testing by Benjamini-Hochberg FDR correction, with FDR < 0.01 considered for 
subsequent analysis.
Single cell RNA-seq analysis—Cells that had fewer than 2000 genes detected, a lower 
than 25% rate of reads mapping to the transcriptome, or were undergoing the cell cycle 
(Kowalczyk et al., 2015) were excluded from analysis. We also excluded outlier cells from 
the MPPs group which were likely caused by cell contamination. To correct for batch issues, 
the two experimental batches were centered to have the same mean log(TP100K+1) 
(hereafter referred to as log(TPM), where TPM stands for ‘transcripts per million’) per gene. 
PCA was done in R with scaled, centered log(TPM), using only genes annotated with GO 
terms we considered important in our system, including cytokine receptor binding, immune 
system development, immune system process, inflammatory response, response to cytokine, 
single-organism developmental process, stem cell, cell proliferation, and autophagy. The 
permutationPA function from jackstraw (Chung and Storey, 2015) was used to select 
significant PCs and then tSNE (tSNE package, with default parameters) was used to reduce 
the data to two dimensions. Density-based clustering was performed (package dbscan, eps 
=5, minPts=20) and the resulting three clusters were used for subsequent analysis.
Single-cell differential expression and gene signatures—All single-cell 
differential expression analysis was performed with single cell differential expression 
(SCDE) (Kharchenko et al., 2014), considering only genes that had at least 50 reads and 
were detected in at least 5 cells. For all signatures, a cell’s signature score is the weighted 
sum of log(TPM) of genes, weighted by the direction of the enrichment (either +1 for 
enriched genes or −1 for depleted genes).
Stimulated myeloid-biased LT-HSC signature.—Genes with a DE FDR <0.1 when 
comparing stimulated LT-HSCs in cluster 3 to cluster 2 were defined as the signature of 
stimulated myeloid-biased LT-HSCs.
Unstimulated myeloid-biased LT-HSC signature.—Genes where bulk RNA-seq data 
indicated a significant difference (FDR<0.01) in expression between both aged vs. young 
unstimulated LT-HSCs, and between cluster 3 vs. cluster 2 LT-HSCs (in the same direction) 
were used as an initial estimate of a common myeloid-biased LT-HSC signature. Next, a 
weighted sum of the genes in this common signature was used to score each of the 
unstimulated LT-HSCs, and the cells were partitioned into two groups on this basis. The 
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centroids of these two groups of cells were used to initialize k-means clustering (k=2) of the 
unstimulated LT-HSCs, performed in PC-space with PCs 2–10 of a PCA of all expressed 
genes in unstimulated LT-HSCs only (PC1 was correlated with batch, and so was excluded 
here). This yielded two new clusters, similar but distinct from those with which we 
initialized the k-means clustering algorithm. SCDE was used to identify differentially 
expressed genes (FDR<0.1) between the cells in these two clusters (representing myeloid-
biased and non-myeloid-biased unstimulated LTs), yielding an unstimulated myeloid-biased 
LT signature.
TF motif analysis—Enhancers from diverse mouse blood cells (Lara-Astiaso et al., 2014) 
were associated with neighboring genes with GREAT (McLean et al., 2010) and each was 
scanned for the mouse and (when mouse was not available) human TF motifs from CIS-BP 
(Weirauch et al., 2014) using an implementation of GOMER (Granek and Clarke, 2005), 
yielding a TF binding score for each TF/enhancer pair. TFs that distinguish cell subsets were 
defined as those that best discriminate between enhancers associated with genes that are 
specific to the subset compared to enhancers that are associated with non-specific, but 
expressed genes using the Wilcoxon rank sum test, yielding an enrichment score (AUROC) 
and P-value. P-values were subsequently corrected for multiple hypothesis testing with FDR 
correction, considering only those with FDR < 0.1 for subsequent analysis.
Statistical tests—All statistical analysis for the phenotypic data was done in Graphpad 
Prism software using an unpaired Student’s T test, or a 1-way or 2-way ANOVA. Data is 
reported as mean ± SEM (statistical test is depicted in each figure legend). Significance 
measurements were marked as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, or ns for not 
significant. P-values were corrected for multiple hypothesis testing by Bonferroni’s multiple 
comparison test.
Replicate information is indicated in the figure legends.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Aged hematopoietic stem cells exposed to inflammatory signals demonstrate increased 
myeloid output in a cell-intrinsic manner.
(A) Schematic overview of the approach. (B)-(E) Young and aged mice were exposed to a 
second dose of LPS 1 month after the initial LPS challenge and the frequency of (B) CD11b
+, (C) Gr-1+, (D) CD3+, and (E) CD19+ was observed for 9 weeks. (F)-(I) LT-HSCs sorted 
from young and aged CD45.2 mice were stimulated with LPS and Pam3csk4 for 2 hours 
prior to competitive transplant into CD45.1 recipients. Peripheral blood CD45.2 (F) CD11b
+, (G) Gr-1+, (H) CD3+ and (I) CD19+ frequencies were measured by flow cytometry at 3 
months post-reconstitution (n = 11–12 per group). Data represent at least two independent 
experiments and are presented as mean ± SEM. * denotes p < 0.05, ** denotes p < 0.01 and 
*** denotes p < 0.001. P-values were corrected for multiple hypothesis testing by 
Bonferroni’s multiple comparison test.
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Figure 2. Early hematopoietic progenitors demonstrate a rapid transcriptional response to 
inflammatory signals.
(A) Schematic of LPS and Pam3CSK4 time-course experiment. LT-HSCs, ST-HSCs and 
MPPs from 5 young and 5 aged mice were exposed to LPS and Pam3CSK4 in vitro for the 
indicated time after which RNA was harvested for bulk RNA-sequencing. (B) Heatmap of 
differentially expressed genes in young and aged hematopoietic progenitors alongside an 
expression map of mature bone-marrow derived dendritic cells (DCs) challenged with LPS 
for comparison. (C) Heatmap of NF-kB regulated inflammatory genes clustered by temporal 
expression patterns described previously. (D) Heatmap of cytokines expressed in early 
progenitors and DCs.
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Figure 3. Single-cell RNA-sequencing reveals heterogeneity in the hematopoietic stem cell 
compartment that is altered with age.
(A)-(E) LT-HSCs, ST-HSCs and MPPs from 5 young and 4 aged mice were stimulated with 
LPS and Pam3CSK4 and sorted for scRNA-seq. scRNA-seq data for all cells, projected on 
two t-SNE axes. (A) Density-based clusters. (B)-(E) Single-cell t-SNE plots (as before) 
indicating all cell types among (B) unstimulated and (C) stimulated cells, and mouse ages 
among (D) unstimulated and (E) stimulated LT-HSCs. (F) Correlation across cells between 
DE genes common to both simulated cluster 3 vs 2 and unstimulated aged vs young LT-
HSCs. Three clusters of correlated genes are identified. (G) Heat-map represents the 
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expression values of genes in the unstimulated myeloid-biased gene signature for each single 
unstimulated LT-HSC. The panels below show the myeloid signature score for each cell and 
is the basis for the ordering of the x axis. The bottom color-coded bar shows the age of the 
animals from which the cells were derived. (H) Enrichment of transcription factor motifs in 
enhancers of cluster 3-vs-2-specific genes for all cells (left), or only aged LT-HSCs (right) 
(x-axis) and differential expression of the TF genes themselves in the same comparison (y-
axis). Significant genes (FDR<0.1) are indicated. An enrichment score > 0.5 indicates that 
the TF motif is enriched among genes that are expressed more highly in cluster 3, while a 
score below 0.5 indicates that the TF is expressed more highly in cluster 2.
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Figure 4. Klf5, Ikzf1, and Stat3 regulate steady-state and inflammatory age-related myeloid bias.
Bone marrow cells from young and aged C57BL/6 mice were transduced with constructs to 
either knock-down (denoted SH in A-F), or overexpress (denoted OE in G-L) the indicated 
transcription factors. These cells were subsequently reconstituted into lethally irradiated 
young C57BL/6 recipient mice. These mice were subsequently challenged with a single sub-
lethal dose of LPS and peripheral blood immune cells were tracked over time by flow 
cytometry. Shown are peripheral blood myeloid cells for mice with knockdown or 
overexpression of (A,G) Ikzf1, (B,H) Klf5, and (C,I) Stat3. These mice were subsequently 
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harvested and the bone marrow was analyzed for the frequency of (D,J) LT-HSCs, (E,K) 
CMPs, and (F,L) CLPs from knockdown and overexpression mice, respectively. Data 
represent at least two independent experiments (n=8–10 mice per group) and are presented 
as mean ± SEM. (A)-(C) and (G)-(H) ^ denotes p<0.05 for aged shRNA or OE vs. Aged 
MG, vdenotes p<0.05 for aged shRNA or OE vs. young MG using two way ANOVA. (D-F, 
J-L) * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001. P-values was 
corrected for multiple hypothesis testing by Bonferroni’s method.
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Figure 5. CD61 expression on LT-HSCs is a marker for mLT-HSCs.
(A) Flow cytometry plots showing CD61 expression in aged and young LT-HSCs. (B)-(E) 
Total LT-HSCs, and those with elevated (CD61-high) and decreased (CD61-low) expression 
of CD61, from aged and young mice were transplanted into lethally irradiated young 
C57BL/6 recipient mice. Mice were subsequently challenged with a single dose of LPS as in 
Figure 1. Shown are the peripheral blood CD11b+ cell frequencies from mice transplanted 
with (B) young and (C) aged donor LT-HSCs, and the peripheral blood Gr-1+ frequencies 
from mice transplanted with (D) young and (E) aged donor LT-HSCs. (F)-(K) Transplanted 
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mice were harvested at 4-months post-reconstitution. Shown are the bone marrow 
frequencies of (F) LT-HSCs, (G) CD61+ LT-HSCs, (H) CLPs, (I) GMPs, (J) CMPs and (K) 
MEPs in these mice. (A) CD61 high frequencies and SD are depicted for aged (red) and 
young (blue) (n=4 per group). (B-K) Data represent at least two independent experiments 
(n=7–12 per group) and are presented as mean ± SEM. ^ denotes p<0.05 for CD61-high vs. 
control, vdenotes p<0.05 for CD61-low vs. control using two way ANOVA. * denotes p < 
0.05, ** denotes p < 0.01 and *** denotes p < 0.001. P-values was corrected for multiple 
hypothesis testing by Bonferroni’s method.
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Figure 6. Model of LT-HSC aging and inflammatory myeloid-bias.
Shifts in clonal heterogeneity during LT-HSC aging affects the inflammatory response of LT-
HSCs. The LT-HSC compartment is comprised of unbiased and myeloid-biased LT-HSCs. 
With age, the clonal distribution of LT-HSCs shifts towards myeloid-biased variants which 
express high levels of CD61. During acute inflammatory challenges, aged myeloid-biased 
LT-HSCs preferentially expand, leading to increased myeloid output. Several cell-intrinsic 
factors, including the transcriptional regulators Klf5, Ikzf1 and Stat3 may play a role in 
establishing a myeloid-biased differentiation program during aging and inflammation. 
Extrinsic factors, including inflammatory cytokines and growth factors secreted from other 
cell types may also play a role.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
CD11c Biolegend 117304 N418
CD3e Biolegend 100304 145–2C11
NK1.1 Biolegend 108704 PK136
IL-7Ra Biolegend 135006 A7R34
Ter-119 Biolegend 116204 TER-119
CD11b Biolegend 101204 M1/70
CD8a Biolegend 100704 53–6.7
CD4 eBioscience 13–0041-82 gk1.5
B220 Biolegend 103204 RA3–6B2
CD19 Biolegend 115504 6D5
GR-1 Biolegend 108403 RB6–8C5
CD45.1 PE Biolegend 110708 a20
CD45.2 eflour 450 eBioscience 48–0454-82 104
GR1 APC Biolegend 108412 RB6–8C5
CD3E FITC Biolegend 100306 145–2C11
CD11B PE/CY5 Biolegend 101209 M1/70
CD45.2 PE/CY5 Biolegend 25–0454-80 104
CD3E PE/CY5 eBioscience 100310 145–2C11
IL-7Ra PE/CY5 Biolegend 135016 A7R34
NK1.1 PE/CY5 Biolegend 108716 PK136
GR1 PE/CY5 Biolegend 108410 RB6–8C5
cd11B PE/CY5 Biolegend 101209 M1/70
CD19 PE/CY5 Biolegend 115510 6D5
CD4 PE/CY5 BIolegend 15–0041–82 GK1.5
TER-119 PE/CY5 EBioscience 116209 TER-119
FC BLOCK Biolegend 101302 93
CD150 PE/CY7 Biolegend 115914 TC15–12F12.2
CD45.2 APC/CY7 Biolegend 109824 104
CD34 EFLOUR450 Biolegend 48–0341–80 RAM34
CD34 PE EBioscience 128610 HM34
IL-7Ra PE Biolegend 135009 A7R34
CD48 PACBLUE Biolegend 103418 HM48–1
CD61 PE Biolegend 12–0611–82 2C9.G3
CD38 APC/CY7 EBioscience 102728 90
CD34 APC/CY7 BIolegend 128614 HM34
CD16/32 EFLOUR450 Biolegend 48–0161–82 93
CD16/32 VIOLET 420 EBioscience 101331 93
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REAGENT or RESOURCE SOURCE IDENTIFIER
CD16/32 PE/CY7 Biolegend 25–0161–81 93
SCA1 APC EBioscience 108112 D7
SCA1 PACBLUE Biolegend 108120 D7
CKIT APC Biolegend 105812 2B8
CKIT PE Biolegend 1335106 ACK2
CKIT FITC Biolegend 105806 2B8
CD135 APC Biolegend 135310 A2F10
CD41 PE Biolegend 133906 B203323
CD51 PE Biolegend 104106 B240646
CD61 APC Biolegend 104316 B219725
Bacterial and Virus Strains
PCL-ecotropic pseudotyped gamma-retrovirus O'Connell et al. J Exp Med. 2008 Mar 17. 205(3):585–
94.
Adgene: #26528
Chemicals, Peptides, and Recombinant Proteins
LPS SIGMA L2880–100MG
Pam3CSK4 Invivogen 41–11–60–10
Dulbecco's Modification of Eagle's Medium Corning 10–013-CV
Fetal Bovine Serum Corning 35–015-CV
Penicillin Streptomycin Solution (100x) Corning 30–002-Cl
0.25% Trypsin Corning 25–053-Cl
TRIzol Reagent Invitrogen 15596026
Protoscript II New England Biolabs M0368L
Antarctic phosphatase New England Biolabs M0289S
Puromycin InvivoGen Cat#ant-pr-1
Murine SCF PeproTech 250–03
Murine IL-6 PeproTech 216–16
Murine IL-3 PeproTech 213–13
Critical Commercial Assays
BioT Bioland B01–01
Nextera XT DNA Library Preparation Kit illumina FC-131–1096
qScript cDNA SuperMix Quanta 95048–100
KAPA HiFi HotStart ReadyMix KAPA biosystems KM2602
Deposited Data
RNA-Seq Gene Expression and IR Data This Paper GEO: GSE100428
Experimental Models: Cell Lines
HEK293T ATCC CRL-3216
Experimental Models: Organisms/Strains
Mouse: C57BL/6J Jackson Laboratory 000664
Mouse: C57BL/6J Charles Rivers Laboratories C57BL/6NCrl
Oligonucleotides - source
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REAGENT or RESOURCE SOURCE IDENTIFIER
Primers used Table S5 This paper
shRNA sequences Table S5 This paper
cDNA sequences for transcription factors over expression Table S5 This paper
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